LTGO Conversion Disclosure
Westlake Biopartners Fund I, L.p. · SEC Form 4 · Filed Aug 11, 2026
Conversion
Reported value range
Not reported
Westlake Biopartners Fund I, L.p. 10% owner
LTGO
Transaction date
Aug 10, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 1 day later
LTGO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series Seed Convertible Preferred Stock on Common Stock
- Quantity / price
- 938,979 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001104659-26-093633
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO Current | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |